ProVen Growth & Income VCT plc
Interim Management Statement
for the three months ended 31 May 2015
ProVen Growth & Income VCT plc (the "Company") presents an Interim Management Statement for the three month period ended 31 May 2015. The statement also includes relevant financial information between the end of the period and the date of this announcement.
Performance
Unaudited 31 May 2015 | Audited 28 Feb 2015 | |||
Pence | Pence | |||
Net Asset Value per share ("NAV") | 85.8 | 85.7 | ||
Dividends paid to date* | 31.1 | 31.1 | ||
Total Return | 116.9 | 116.8 |
* Dividends paid represents dividends paid in respect of the Original 'C' Shares between their launch in 2006 up until their conversion in 2009 and as Ordinary Shares since the 'C' Share conversion. 'C' Shares were converted into Ordinary Shares on a one for one basis in 2009.
Dividends paid or declared
On 18 June 2015, the Company announced a final dividend for the year ended 28 February 2015 of 2.5p per share. Having received approval at the Annual General Meeting of the Company on 22 July 2015, the dividend will be paid on 31 July 2015 to shareholders on the register at 3 July 2015.
Investment portfolio summary at 31 May 2015
Valuation | |
£'000 | |
Venture capital investments | |
Cognolink Limited | 4,645 |
D30 Holdings Limited | 2,960 |
Pulpitum Limited | 2,704 |
MEL TopCo Limited (t/a Maplin) | 2,496 |
Abzena plc | 2,483 |
MyOptique Group Limited | 2,400 |
APM Healthcare Limited | 2,356 |
Speciality European Pharma Limited | 2,307 |
Inskin Media Limited | 2,301 |
Monica Vinader Limited | 2,263 |
Other investments | 23,520 |
50,435 | |
Cash at bank | 27,467 |
Total | 77,902 |
Quoted investments are valued at the closing bid price at 31 May 2015, discounted where appropriate. Unquoted investments are valued at fair values established using the International Private Equity and Venture Capital Valuation Guidelines.
Investment activity during the three month period ended 31 May 2015
Investment additions
£'000 | |
D30 Holdings Limited | 2,960 |
Sealskinz Holdings Limited | 2,130 |
InContext Solutions Inc | 675 |
Big Data Partnership Limited | 432 |
Disposable Cubicle Curtains Limited | 288 |
Chess Technologies Limited | 259 |
Senselogix Limited | 18 |
6,762 |
Investment disposals
Cost | Market value at 1 March 2015 | Disposal proceeds | Gain/(loss) against cost | Realised gain/(loss) in period | |
£'000 | £'000 | £'000 | £'000 | £'000 | |
Eagle-I Music Limited | 851 | 509 | 459 | (392) | (50) |
Saffron Digital Limited* | - | 69 | 69 | 69 | - |
Celoxica Limited | 61 | 61 | 61 | - | - |
Speciality European Pharma Limited | 55 | 55 | 55 | - | - |
Peerius Limited | 48 | 48 | 48 | - | - |
Long Eaton Healthcare Limited | - | 16 | 23 | 23 | 7 |
1,015 | 758 | 715 | (300) | (43) |
*Investment previously realised but further proceeds received
Investment activity from 1 June 2015 to the date of this announcement
Investment additions
£'000 | |
Big Data Partnership Limited | 259 |
Investment disposals
Cost | Market Value at 1 March 2015 | Disposal proceeds | Gain against cost | Realised gain in period | |
£'000 | £'000 | £'000 | £'000 | £'000 | |
MEL TopCo Limited (t/a Maplin) | 279 | 279 | 279 | - | - |
Speciality European Pharma Limited | 55 | 55 | 55 | - | - |
Celoxica Limited | 41 | 41 | 41 | - | - |
Peerius Limited | 33 | 33 | 33 | - | - |
408 | 408 | 408 | - | - |
Changes to share capital
Ordinary Shares of 1.6187p each | |
As at 1 March 2015 | 72,475,003 |
Shares issued during the 3 months to 31 May 2015 | 17,842,141 |
Shares bought back during the 3 months to 31 May 2015 | - |
As at 31 May 2015 | 90,317,144 |
In the period from 1 June 2015 to the date of this announcement, 410,993 Ordinary Shares were repurchased and subsequently cancelled.
Material events
Other than the matters described above, there were no material events during the period from 1 March 2015 to 31 May 2015 or in the period from 1 June 2015 to the date of this announcement.
Further information
Further information regarding the Company, can be found on Beringea's dedicated VCT website: www.provenvcts.co.uk or by contacting Beringea, the Investment Manager, at provenvcts@beringea.co.uk or by telephone on 020 7845 7820.
Beringea LLP
Company Secretary
Telephone 020 7845 7820
-End